Michelle K. Y's team had confirmed that PDK1 could promote the development of ovarian cancer especially in metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling 29. This evidence concerns the gene CXCL8 and neoplasm.